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ARTICLE
PARP1 and PARP2 stabilise replication forks at base
excision repair intermediates through Fbh1-
dependent Rad51 regulation
George E. Ronson1, Ann Liza Piberger2, Martin R. Higgs2, Anna L. Olsen3, Grant S. Stewart 2, Peter J. McHugh3,
Eva Petermann2 & Nicholas D. Lakin 1
PARP1 regulates the repair of DNA single-strand breaks generated directly, or during base
excision repair (BER). However, the role of PARP2 in these and other repair mechanisms is
unknown. Here, we report a requirement for PARP2 in stabilising replication forks that
encounter BER intermediates through Fbh1-dependent regulation of Rad51. Whereas PARP2
is dispensable for tolerance of cells to SSBs or homologous recombination dysfunction, it is
redundant with PARP1 in BER. Therefore, combined disruption of PARP1 and PARP2 leads to
defective BER, resulting in elevated levels of replication-associated DNA damage owing to an
inability to stabilise Rad51 at damaged replication forks and prevent uncontrolled DNA
resection. Together, our results demonstrate how PARP1 and PARP2 regulate two indepen-
dent, but intrinsically linked aspects of DNA base damage tolerance by promoting BER
directly, and by stabilising replication forks that encounter BER intermediates.
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The genome of organisms is under constant assault from avariety of agents that cause DNA damage. As such cellshave evolved a DNA damage response (DDR) that detects
and repairs DNA lesions to restore genome integrity1. A central
component of this response is signalling DNA damage to effector
proteins through post-translational modiﬁcations including
phosphorylation, ubiquitylation, SUMOylation, acetylation and
ADP-ribosylation2. This, in turn, regulates a variety of processes
such as cell cycle arrest and DNA repair that are critical to
maintain genome integrity. The importance of these pathways is
underscored by the observations that defects in these pathways
leads to chromosome instability and a variety of pathologies,
including increased cancer risk.
ADP-ribosyltransferases (ARTDs), or poly(ADP-ribose) poly-
merases (PARPs), attach ADP-ribose onto target proteins either
as single units or polymer chains by mono-ADP ribosylation
(MARylation) or poly-ADP ribosylation (PARylation), respec-
tively3. Of the 17 human genes containing predicted ARTD
catalytic domains4, several have been identiﬁed as primary
sensors of DNA damage5. PARP1, the founding member of the
ARTD family, senses DNA single-strand breaks (SSBs) induced
either directly, or as a consequence of processing DNA lesions
during the base excision repair (BER) pathway6. PARP1 becomes
activated upon binding SSBs and PARylates a variety of substrates
to promote the accumulation of XRCC1 at damage sites that
subsequently acts as a scaffold to assemble repair factors at the
break7–10. PARP1 also regulates pathways other than SSB repair
(SSBR) including replication fork progression and restart11–13,
although the mechanisms of this regulation are unclear. It also
promotes alternative non-homologous end-joining (alt-NHEJ), a
pathway activated in the absence of core NHEJ14,15. Whereas
PARP1 has also been implicated in canonical NHEJ13,16, PARP3
promotes this pathway by facilitating accumulation of repair
factors such as APLF and Ku at damage sites17–19.
Although PARPs regulate several different DNA repair
mechanisms, it is unclear how overlapping functions between
these enzymes promotes cell viability in the face of genotoxic
stress. For example, PARP2 has been implicated in repair of DNA
base damage20,21 and redundancy between PARP1 and PARP2 is
implied by embryonic lethality of parp1−/−parp2−/− mice20.
However, the role of PARP2 in regulating DNA repair and its
relationship to PARP1 in this process remain unknown. More-
over, whether disruption of PARP-dependent SSBR results in
elevated levels of DNA damage that are channelled through
alternate repair mechanisms, how these lesions are processed, and
whether this is also regulated by PARPs is unclear. Given PARP1
and PARP2 are both targets for inhibitors being used to treat
tumours with defects in homologous recombination (HR)22,23,
unravelling these complexities will be important not only for
understanding the mechanistic basis of DNA repair, but also
reﬁning the use of PARP inhibitors (PARPi) in the clinic and
guiding the development of novel PARPi with new mechanisms
of action.
Here we address these questions by disrupting PARP1 and
PARP2 alone or in combinations and assessing the impact of
these manipulations on the repair of DNA base damage. We
identify that PARP1 and PARP2 are redundant in BER and allow
cells to tolerate DNA base damage induced by methyl methane-
sulfonate (MMS). Surprisingly, we ﬁnd that redundancy between
PARP1 and PARP2 does not extend to synthetic lethality with HR
deﬁciency and that loss of PARP1 is the major driver of this
phenotype. Moreover, in the absence of PARP1, PARP2 is
required for optimal resolution of MMS-induced DNA damage
during DNA replication, independent of its role in BER, by sta-
bilising HR proteins at sites of replication stress to protect stalled
and/or damaged forks against uncontrolled nucleolytic resection.
Results
PARP1 and PARP2 are redundant in BER. In order to under-
stand the contributions of different PARP family members in
regulating DNA repair, we generated a number of cell lines
deﬁcient for PARPs in U2OS cells, starting with PARP1 (Fig. 1a
and Supplementary Fig. 1). Consistent with the role of PARP1 in
BER and SSBR6, parp1Δ cells exhibit sensitivity to the DNA-
alkylating agent MMS and the oxidative DNA damage agent
H2O2 (Fig. 1a and Supplementary Fig. 2a). However, although
MMS-induced nuclear ADP-ribosylation is signiﬁcantly reduced
in parp1Δ cells, it is not completely defective (Fig. 1d), and the
PARP inhibitor olaparib further sensitises parp1Δ cells to this
agent (Fig. 1b). Taken together, these data indicate that whilst
PARP1 is required for the cellular response to DNA base
alkylation, in its absence an additional PARP(s) responds to this
variety of DNA damage.
Given olaparib is also able to inhibit PARP222,23, we assessed
whether this ARTD also contributes towards the cellular response
to MMS by disrupting the PARP2 gene either alone or in
combination with PARP1 to generate parp2Δ and parp1/2Δ cell
lines (Fig. 1c and Supplementary Fig. 3). Disruption of PARP2
alone has little impact on MMS-induced nuclear ADP-
ribosylation or the sensitivity of cells to DNA damage induced
by this agent (Fig. 1d, e). Strikingly, the residual ADP-ribosylation
observed in parp1Δ cells is lost upon deletion of PARP2 (Fig. 1d)
and parp1/2Δ cells are more sensitive to MMS than when PARP1
is disrupted alone (Fig. 1e). Importantly, depletion of PARP2 by
siRNA also sensitises parp1Δ U2OS and parp1Δ RPE-1 cells to
MMS (Supplementary Fig. 4 and 5), illustrating a reproducible
phenotype using two independent gene depletion strategies in
different cell lines. To establish whether redundancy between
PARP1 and PARP2 in tolerance of cells to MMS is reﬂected in
their ability to repair SSBs generated during BER, we performed
alkaline comet assays following exposure of parp1Δ, parp2Δ and
parp1/2Δ cells to MMS to directly assess the kinetics of SSB
resolution (Fig. 1f). Disruption of PARP1 or PARP2 alone has no
marked impact on repair of SSBs generated in response to MMS.
In contrast, parp1/2Δ cells show a signiﬁcant increase in the
induction of DNA strand breaks in response to MMS that persist
up to 6 h after removal of the genotoxin. Taken together, these
data indicate that in the absence of PARP1, PARP2 has a key
functional role in signalling DNA damage to promote SSB
resolution and cell survival in response to MMS.
PARP1 is synthetic lethal with HR. Synthetic lethality between
PARP inhibition and HR deﬁciency is mediated through targeting
PARPs at DNA SSBs24,25. Given our ﬁndings that PARP1 and
PARP2 are redundant in BER, we considered whether this rela-
tionship extends to synthetic lethality with HR deﬁciency. Cur-
rently available PARPi target PARP1, PARP2 and PARP322,23.
Therefore, we also wished to establish which combination of
DNA damage responsive PARP disruptions exhibits the strongest
impact on cell viability in combination with HR dysfunction. To
address these questions, we inhibited HR in different PARP-
deﬁcient backgrounds using B02, a small molecule inhibitor of
Rad51 that disrupts its binding to single stranded DNA during
nucleoﬁlament formation in vitro and in vivo, resulting in
defective HR26. As predicted, B02 inhibits Rad51 foci formation
in U2OS cells exposed to MMS or the DSB-inducing agent
phleomycin (Supplementary Fig. 6). Consistent with conservation
of the synthetic lethal relationship between HR deﬁciency
induced by B02 and PARP inhibition, cells treated with PARPi
are more sensitive to B02 than untreated cells (Fig. 2a).
In addition, PARPi sensitivity is suppressed by the addition of
DNA-PKcs inhibitors (DNA-PKi; Fig. 2a), an observation that
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Fig. 1 PARP1 and PARP2 are redundant in the cellular response to MMS-induced DNA damage. a Whole cell extracts were prepared from U2OS or two
independent parp1Δ cell lines and western blotting performed with the indicated antibodies (left panel). U2OS or parp1Δ cell lines were exposed to MMS
and cell survival assessed by clonogenic assays (right panel). Error bars represent the standard error of the mean (SEM) from three independent
experiments. Statistical signiﬁcance was determined by two-way ANOVA (*** p < 0.001). b U2OS or parp1Δ cell lines, with or without exposure to Olaparib
(PARPi), were exposed to MMS and cell survival assessed by clonogenic assays. Error bars represent the SEM from three independent experiments.
Statistical signiﬁcance was determined as in a. c Whole cell extracts were prepared from U2OS, parp1Δ, parp2Δ and parp1/2Δ cells and Western blotting
performed using the indicated antibodies. d The indicated cell lines were left untreated (-) or exposed to 1.5 mM MMS (+ ) for 1 h and nuclear ADP-
ribosylation analysed by immunoﬂuorescence. Error bars represent the SEM from three independent experiments. Statistical signiﬁcance was determined
using a two-tailed Student’s t-test (** p < 0.01; *** p < 0.001). e U2OS, parp1Δ, parp2Δ or parp1/2Δ cell lines were exposed to MMS and cell survival
assessed by clonogenic assays. Error bars represent the SEM from three independent experiments. Statistical signiﬁcance was determined as in a. f Cells
were treated with 250 µM MMS for 1 h, before recovery in fresh media. Samples were taken at the indicated times post treatment and the alkaline comet
assay used to reveal strand breaks and alkali-labile sites. Comet data was normalised to the untreated sample. Error bars represent mean values ± SD from
at least six independent experiments. Statistical signiﬁcance was determined as in d
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was originally made in BRCA2−/− models27, further validating
this as an appropriate assay to assess the impact of different
PARP gene disruptions on cell viability in an HR-deﬁcient
background.
Whereas parp1Δ cells are more sensitive than U2OS cells to HR
inhibition, parp2Δ cells showed no sensitivity to B02. In striking
contrast to the relationship observed with MMS, parp1/2Δ cells
are no more sensitive to B02 than parp1Δ cells (Fig. 2b). The
absence of PARP3 had no impact on the survival of cells
following exposure to B02 irrespective of the presence or absence
of PARP1 and PARP2 (Fig. 2c). Additionally, U2OS and parp3Δ
cells can be equally sensitised to B02 by treatment with olaparib
(Supplementary Fig. 7d), further conﬁrming that PARP3
disruption is not toxic in combination with HR deﬁciency. The
lack of redundancy between PARP1 and PARP2 in cell viability
with HR inhibition is in striking contrast to the context of SSB
resolution during BER (Fig. 1e, f), suggesting that SSBR defects
per se are not toxic with HR dysfunction. In support of this
hypothesis, depletion of the key BER/SSBR protein XRCC1 is
unable to dramatically sensitise cells to B02 (Fig. 2d). Taken
together, these data indicate that whilst PARP1 and PARP2 are
redundant in terms of BER/SSBR, PARP1 is the major PARP
whose disruption is toxic with HR deﬁciency.
PARP1 and PARP2 promote repair of DNA damage during
S-phase. Whereas parp1Δ cells are sensitive to MMS, resolution
of breaks generated during BER is relatively normal in these cells
(Fig. 1f). In addition, although PARP2 promotes tolerance of cells
to MMS in the absence of PARP1, this redundancy is not evident
following exposure of cells to H2O2, an agent that induces DNA
SSBs directly (Supplementary Fig. 2b). Together, these data
suggest the redundancy between PARP1 and PARP2 in the
cellular response to MMS extends beyond a simple role of
these enzymes in regulating BER. BER is initiated by recognition
and excision of the damaged base using DNA glycosylases.
The resulting apurinic (AP) site is subsequently cleaved by
AP-endonuclease 1 (APE1), leading to a DNA strand break that is
channelled through XRCC1 and PARP1-dependent SSBR6.
Although BER is a major mechanism for repair of alkylated base
damage6,28, MMS also induces DNA damage during S-phase
when SSBs created by APE1 cleavage are converted to DSBs by
active replication forks29,30. Therefore, we also considered the
role of PARP1 and PARP2 in resolution of S-phase-associated
DNA damage induced by MMS.
To address this question we labelled cells undergoing S-phase
with the base analogue 5-ethynyl-2’-deoxyuridine (EdU) to
monitor DNA damage either in G1/G2 cells, or cells undergoing
DNA replication at the time of DNA damage induction (Fig. 3a).
Consistent with a previous report30, we observe an increase in γ-
H2AX foci in cells undergoing DNA replication at the time of
MMS exposure, with no detectable induction of γ-H2AX foci in
G1 or G2 cells at the doses employed in this assay (Fig. 3b). No
signiﬁcant increase in MMS-induced γ-H2AX foci is apparent in
replicating parp1Δ or parp2Δ cells compared to U2OS cells. In
contrast, the induction of γ-H2AX foci is signiﬁcantly elevated in
parp1/2Δ cells, indicating an increase in the levels of S-phase
associated DNA damage. To understand whether loss of PARP1
and/or PARP2 affects repair of this damage, we assessed the
kinetics of γ-H2AX foci decay at times following removal of
MMS. 12 h after induction of DNA damage U2OS cells show a
decay in the number of γ-H2AX foci, with levels approaching
those observed in untreated cells (Fig. 3c). Whilst decay of
γ-H2AX foci in parp2Δ cells is comparable to parental U2OS,
c
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parp1Δ cells show a mild delay in the repair of this damage.
Strikingly however, parp1/2Δ cells exhibit a signiﬁcant persistence
of γ-H2AX foci above that observed in parp1Δ cells, indicating
resolution of DNA damage is compromised (Fig. 3c).
Given that disruption of PARP1 and PARP2 results in delayed
ligation of DNA breaks (Fig. 1f), a potential explanation for the
persistent γ-H2AX foci in replicating parp1/2Δ cells is that the
greater number of unrepaired SSBs in these cells results in
elevated levels of S-phase-associated DNA damage that requires a
longer time for repair. Alternatively, PARP1 and/or PARP2 may
have a BER-independent role in resolving DNA damage induced
by MMS speciﬁcally during DNA replication. To distinguish
between these two possibilities we depleted XRCC1, a protein
whose knockdown or mutation delays BER and sensitises cells to
MMS31–34, and assessed whether this could recapitulate the
delayed γ-H2AX decay in a PARP-independent manner. The
levels of γ-H2AX foci induced in replicating cells following
exposure to MMS increases slightly in XRCC1-depleted cells,
presumably through active replication forks encountering unre-
paired SSBs (Fig. 3d). Importantly, decay of these foci is relatively
normal, resulting in signiﬁcantly fewer foci at later time points
compared to parp1/2Δ cells, indicating a BER defect alone cannot
explain the persistent γ-H2AX foci that result from PARP1 and
PARP2 gene disruption. To establish whether PARP1, PARP2 or
both are required for this BER-independent replication repair
event, we depleted XRCC1 in U2OS, parp1Δ, parp2Δ, and parp1/
2Δ cells and assessed γ-H2AX decay after MMS treatment
(Fig. 3e). XRCC1-depleted parp1Δ cells show a marked delay in
the resolution of γ-H2AX. Decay of γ-H2AX foci in XRCC1-
depleted parp2Δ cells are comparable to U2OS cells. However,
depletion of XRCC1 in parp1/2Δ cells compromises the decay of
γ-H2AX above that observed in XRCC1-depleted parp1Δ cells.
Taken together, these data indicate a role for PARP1 in
facilitating replication-associated repair independently of BER
and that in its absence PARP2 can contribute to resolution of
MMS-induced DNA damage during S-phase.
PARP1 and PARP2 regulate Rad51 assembly at replication
forks. Given the importance of PARP1 and PARP2 in resolving
DNA damage during S-phase, we next assessed whether MMS
stalls active replication forks and the impact of disrupting PARP1
and PARP2 on their restart. To achieve this, we used DNA ﬁbre
analysis in conjunction with a labelling protocol that allowed us
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to monitor stalled replication tracts induced by MMS and their
subsequent recovery following its removal. Ongoing forks were
labelled with CldU before stalling by addition of MMS. Following
washout of MMS and CldU, cells were released into fresh IdU-
spiked media, thereby ensuring that only ongoing and restarted
replication forks incorporate the second label whilst the
remaining stalled forks appear as CldU-only tracts (Fig. 4a). MMS
induced replication fork stalling, with the number of stalled forks
decreasing following the removal of MMS, indicating replication
fork recovery (Fig. 4a). Interestingly, whereas a comparable
number of stalled forks are apparent in parp1Δ and parp2Δ cells
relative to U2OS cells, parp1/2Δ cells showed a signiﬁcantly lower
amount of fork stalling at the earliest time point of release
(Fig. 4a). Although the number of stalled forks were lower in
parp1/2Δ cells throughout the recovery period, the kinetics of
restart were similar to U2OS, parp1Δ and parp2Δ cells. Taken
together, these data indicate that loss of PARP1 and PARP2
impair fork stalling at MMS-damaged replication templates
rather than restart of stalled and/or damaged replication forks.
An inability to slow/stall replication forks in response to a
variety of DNA-damaging agents is a characteristic outcome of
disrupting genes involved in HR12,35,36. Given disruption of
PARP1 and PARP2 results in a similar reduced ability to stall
replication forks in response to MMS (Fig. 4a), a phenotype also
observed in Rad51-depleted U2OS cells (Supplementary Fig. 8),
we next considered whether this effect is a consequence of
defective HR. A central component of the HR pathway is assembly
of Rad51 at resected DNA termini to stabilise stalled/collapsed
replication forks to facilitate their restart once repair is complete37.
Therefore, we assessed the formation and decay of Rad51 foci in
our parpΔ cell lines at time points following a transient exposure
to MMS. Parental U2OS, parp1Δ and parp2Δ cells exhibit robust
induction of Rad51 foci in EdU-positive cells following a transient
exposure to MMS, peaking at 6 h (Fig. 4b). However, whilst decay
of these foci over time is similar between U2OS and parp2Δ cells,
they persist in parp1Δ cells indicating delayed kinetics of DNA
repair and/or that elevated levels of DNA damage are channelled
through a Rad51-dependent repair mechanism. Interestingly,
although we observed a slight induction and decay of Rad51 foci
in parp1/2Δ cells, this was at a lower level to what we observed in
the absence of PARP1 or PARP2 (Fig. 4b), suggesting these cells
have difﬁculties in assembly and/or maintenance of Rad51 at
damaged replication forks induced by MMS.
To better understand this observation, we also considered the
role of PARP1 and PARP2 in regulating HR by assessing Rad51
foci in our parpΔ cell lines when SSBR has been compromised
independently of PARP status. Depletion of XRCC1 results in
elevated levels of Rad51 foci that continue to accumulate up to 12
h following removal of MMS in U2OS, parp1Δ and parp2Δ cells
(Fig. 4b). This observation was also recapitulated in replicating
RPE-1 and MRC5 cells depleted of XRCC1 following exposure to
MMS (Supplementary Fig. 9), indicating that disruption of SSBR/
BER leads to elevated levels of S-phase associated DNA damage
that is channelled through Rad51-dependent repair in several
different cell lines. Strikingly, this increase in Rad51 foci is
compromised in parp1/2Δ cells, or U2OS cells treated with
olaparib (Fig. 4b, c). PARPi similarly decreases the number of
strong MMS-induced Rad51 foci in MRC5 and RPE-1 cells
(Supplementary Fig. 9), as does depletion of PARP2 in parp1Δ
RPE-1 cells (Supplementary Fig. 10). Together, these data indicate
novel redundancy between PARP1 and PARP2 in the assembly
and/or stabilisation of Rad51 at sites of stalled/damaged
replications forks in multiple cell lines. Moreover, whereas
inhibition of Rad51 using B02 induces a striking increase in
persistent γ-H2AX foci following a transient exposure of U2OS
cells to MMS, it does not induce a similarly large increase in
parp1/2Δ cells (Fig. 4d). These data suggest that Rad51 and
PARP1/PARP2 function in the same pathway with regards to the
resolution of S-phase associated DNA damage induced by MMS,
providing an explanation for the persistent γ-H2AX foci observed
in parp1/2Δ cells.
PARP1 and PARP2 stabilise Rad51 at damaged replication
forks. PARP1 has previously been implicated in the restart of
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Fig. 4 Assembly of Rad51 at damaged replication forks is compromised in
the absence of PARP1 and PARP2. a DNA ﬁbre analysis was performed in
the indicated cells after MMS exposure and recovery for the times shown.
The number of stalled forks (red-only tracts) was determined as a ratio of
all red-labelled replication structures. These values were subsequently
normalised to the equivalent ratio in the corresponding non-treated sample.
Error bars represent the SEM from at least three independent experiments.
Statistical signiﬁcance from the normalised ratio of stalled forks in parental
U2OS cells was determined using a two-tailed Student’s t-test (NS, not
signiﬁcant; * p < 0.05; ** p < 0.01; *** p < 0.001). b The indicated cell lines
transfected with control or XRCC1 siRNA were treated with 1 μM EdU
(Unt), or with 1 μM EdU and 0.5 mM MMS for 1 h before recovery in fresh
media, and Rad51 foci quantiﬁed in EdU-positive cells. Times indicated
show hours since addition of EdU and MMS. Error bars represent the SEM
from three independent experiments. Statistical signiﬁcance was
determined as in a. c U2OS cells transfected with control or XRCC1 siRNA
were treated as in b and Rad51 nuclear foci analysed in EdU-positive cells.
Cells were ﬁxed 12 h after addition of EdU and MMS. Error bars represent
the SEM from three independent experiments. Statistical signiﬁcance was
determined as in a. d U2OS or parp1/2Δ cells, in the presence or absence of
50 μM B02 (Rad51i), were treated as in (3 C) and γ-H2AX foci quantiﬁed in
EdU-positive cells. Times indicated show hours since addition of EdU and
MMS. Error bars represent the SEM from three independent experiments.
Statistical signiﬁcance was determined as in a
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stalled replication forks through a mechanism that is dependent
on Mre11, suggesting that DNA end resection is a critical control
point regulated by PARPs11,13. To investigate this possibility in
the context of replication stress induced by DNA base alkylation,
we assessed ssDNA formation by monitoring RPA foci in EdU-
positive cells following a transient exposure to MMS. Similar to
Rad51 foci (Fig. 4b), U2OS and parp2Δ cells exhibit a transient
induction of RPA foci following exposure to MMS, whereas they
persist in parp1Δ cells (Fig. 5a). Depletion of XRCC1 induces a
continued accumulation of RPA foci in U2OS, parp1Δ and
parp2Δ cells (Fig. 5b), further supporting the notion that defective
SSBR/BER increases DNA damage that is channelled through
HR. Strikingly, RPA foci and RPA phosphorylation on serine-4/8
(S4/8) are increased in parp1/2Δ cells above that observed upon
depletion of XRCC1 alone, or in combination with parp1 and
parp2 gene disruption (Fig. 5a–c), indicating increased levels of
ssDNA in these cells above that attributable to defects in SSB/
BER. Taken together, these data indicate that although PARP1
and PARP2 are redundant in the assembly of Rad51 at sites of
stalled/damaged replication forks induced by MMS, this is not
regulated through controlling DNA end-resection.
Rad51 protects nascent DNA from degradation at stalled
replication forks and loss of factors required for loading Rad51
onto DNA, such as BRCA2 and FANCD2 results in extensive
nucleolytic degradation of DNA ends38–40. Therefore, one
plausible explanation for the extensive ssDNA formation in
MMS-treated parp1/2Δ cells is that loading of factors required to
assemble Rad51 onto resected DNA ends is defective. Recently,
however, several DNA helicases have been identiﬁed that control
the stability of a Rad51 nucleoﬁlament41–43. Therefore, an
alternative interpretation of our observations is that PARPs
regulate Rad51 stability at sites of stalled/damaged replication
forks, as opposed to recruitment of Rad51 to sites of replication
stress per se. To assess these two possibilities, we depleted F-Box
DNA helicase 1 (Fbh1), a factor capable of displacing Rad51 from
nucleoﬁlaments and suppressing HR43,44. Depletion of Fbh1
results in a slight increase in Rad51 foci formation in replicating
U2OS cells at an early time point following exposure to MMS,
although they decay to a similar extent to that observed in control
cells (Fig. 5e). Strikingly, however, it restores Rad51 foci
formation in PARPi treated U2OS, RPE-1 and MRC5 cells
(Fig. 5d and Supplementary Fig. 11), or parp1/2Δ U2OS cells
(Fig. 5e). In addition, PARPi do not signiﬁcantly decrease the
levels of PALB2 enriched in chromatin following exposure of cells
to MMS, indicating that the ability of this accessory factor
required for loading Rad51 at sites of DNA damage is not affected
by PARP status (Fig. 5f). We observe that loss of PARP1 and
PARP2 also compromises Rad51 foci formation in response to
hydroxyurea (HU), and that this defective Rad51 foci formation
can be similarly restored by depletion of Fbh1 (Supplementary
Fig. 12), indicating that this observation is not restricted to MMS-
induced replication stress. Furthermore, and consistent with
problematic Rad51 retention, replication fork stability is also
severely compromised after prolonged HU exposure upon
combined loss of PARP1 and PARP2 (Supplementary Fig. 12).
Taken together, these data support the notion that PARP1 and
PARP2 do not regulate the recruitment of Rad51 to stalled and/or
damaged replication forks, but instead act to stabilise Rad51
nucleoﬁlaments to promote repair of replication-associated DNA
damage induced by MMS.
Discussion
Our observations that parp1Δ cells can be further sensitised to
MMS by PARPi indicate an additional PARP(s) is required for
the cellular response to DNA base alkylation. Our data indicate
PARP2 performs this role and we uncover strong redundancy
between PARP1 and PARP2 in the cellular response to DNA base
alkylation. PARP2 was originally proposed as a possible ARTD
responsible for residual DNA damage-induced ADP-ribosyla-
tion45,46. Consistent with this hypothesis, we observe that residual
MMS-induced ADP-ribosylation in parp1Δ cells is signiﬁcantly
reduced by disruption of parp2 (Fig. 1d). Moreover, disruption of
parp2 in a parp1Δ background further sensitises cells to MMS and
parp1/2Δ cells exhibit a delay in resolution of this damage com-
pared to U2OS, parp1Δ and parp2Δ cells (Fig.1e, f). Given PARP2
is recruited to laser induced DNA damage sites after PARP147, it
is tempting to speculate that PARP2 lies downstream of PARP1
in the SSBR pathway. However, it is noteworthy that disruption of
parp2 does not further sensitise parp1Δ cells to SSBs induced by
H2O2 (Supplementary Fig. 2b) or delay the resolution of DNA
breaks induced by this agent, even in the absence of PARP148,49.
Moreover, effective resolution of breaks generated during BER is
apparent in the absence of PARP1 or PARP2, arguing against an
absolute requirement for either of these enzymes alone in this
process. Together, these data support redundant roles for PARP1
and PARP2 in BER, as opposed to SSBR more generally.
It is well documented that PARPi are toxic to cells with defects
in HR24. However, given currently available PARPi target mul-
tiple ARTDs22,23, which PARP is the most effective to target in
synthetic lethal strategies with HR deﬁciency remains an open
question. Our ﬁndings indicate that inhibition of HR is toxic to
cells disrupted in PARP1 (Fig. 2b). Cells are able to tolerate HR
inhibition equally well in the presence or absence of PARP3
(Fig. 2c), in keeping with the observations that AZD2461, a
compound that inhibits PARP1 and PARP2 but not PARP3,
effectively causes BRCA-mutated tumour regression50.
PARP2 status does not markedly affect the ability of cells to
survive HR inhibition, even in the absence of PARP1 (Fig. 2b).
This is surprising given the redundancy between PARP1 and
PARP2 in repair of DNA base alkylation induced by MMS
(Fig. 1). However, it should be noted that we do not observe
redundancy between PARP1 and PARP2 in sensitivity of cells to
H2O2, an agent that induces oxidative DNA damage that might
more accurately reﬂect the type of DNA lesion encountered by
replication forks in a physiological setting. We also observe that
depletion of the key SSBR factor XRCC1 has little impact on the
ability of cells to tolerate HR inhibition (Fig. 2d), supporting the
model that PARPi toxicity is driven by trapping the PARPs at
SSBs to elicit replication blockage, as opposed to SSBR defects
per se25,51. However, parp1Δ cells are clearly sensitive to B02,
indicating PARP trapping is not the only factor that drives
toxicity with HR inhibition. Importantly, our data clearly indicate
that disruption of PARP1 is more toxic with HR inhibition than
loss of either PARP2 or PARP3. Given PARP2 is essential for
hematopoietic stem/progenitor cell survival52, our observations
would support the development of PARP1 selective inhibitors
that may limit off-target effects associated with broader speciﬁcity
compounds.
Taken together, our data support an additional role of PARP1
and PARP2 in allowing cells to tolerate DNA base alkylation
beyond their regulation of BER/SSBR. We clearly identify that
whilst PARP1 and PARP2 are required for canonical BER, they
are also required to resolve replication-associated DNA damage
during DNA synthesis. Our data identifying that decay of
γ-H2AX foci is delayed in parp1Δ cells indicate that this is
attributable, in part, to PARP1. Strikingly however, this
phenotype is exacerbated in parp1/2Δ cells, indicating further
redundancy between PARP1 and PARP2 in repair of replication-
associated DNA damage induced by MMS. S-phase associated
γ-H2AX foci induced by MMS are suppressed by depletion of
N-methylpurine DNA glycosylase or AP-endonuclease, the
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enzymes that remove the methylated base and perform the strand
incision step to initiate BER30. This supports the notion that
PARP1 and PARP2 are required to repair S-phase-associated
DNA DSBs that arise as a consequence of replication forks
encountering SSBR intermediates generated during BER. Deple-
tion of XRCC1 does not result in a similar persistence of MMS-
induced γ-H2AX foci (Fig. 3d, e), indicating that XRCC1 does not
contribute signiﬁcantly to replication-associated repair in this
context. Importantly, however, this also supports a model
whereby the inability to resolve DNA damage in the absence of
PARP1 and PARP2 is independent of BER, identifying a direct
role of these enzymes in repair of MMS-induced DNA damage
during S-phase. Thus, PARP1 and PARP2 are critical for two
separate but linked aspects of repair of alkylated DNA base
damage; one through regulating BER, in addition to repair of
replication-associated DNA strand breaks generated as a con-
sequence of unresolved SSB intermediates resulting in replication
stress.
HR protects cells from replication-associated DSBs induced by
MMS53 and PARP1 has been implicated in the slowing and/or
restart of replication forks in response to genotoxins11–13,54.
However, whether PARP1 regulates HR at stalled/damaged
replication forks, how this is achieved, and the role of PARP2 in
these events is unclear. Our data demonstrate a critical require-
ment for PARP1 and PARP2 in stabilising the Rad51 nucleoﬁ-
lament at damaged replication forks. Whereas an induction of
Rad51 foci is evident in replicating U2OS, parp1Δ and parp2Δ
cells exposed to MMS, their decay is delayed in the absence of
PARP1 (Fig. 4b), indicating either a problem in resolving HR
intermediates, or increased levels of DNA damage being chan-
nelled through HR. Importantly, we observe that XRCC1 deple-
tion results in persistent Rad51 foci in several different cell lines
(Fig. 4b and Supplementary Fig. 9), supporting the notion that
defective SSBR/BER results in elevated levels of DNA damage that
are channelled through Rad51-dependent repair mechanisms.
Strikingly, however, we observe that in the absence of PARP1 and
PARP2, replication fork stalling and assembly of Rad51 at sites of
replication stress induced by MMS are compromised (Fig. 4a, b
and Supplementary Fig. 10). Given the critical role of Rad51 in
the stabilisation, repair and restart of damaged replication forks,
this provides an explanation for the persistent levels of DNA
damage in these cells.
The ability to form RPA foci in response to MMS independent
of PARP status would argue against DNA end-resection being
point at which PARP1 and PARP2 regulate assembly of Rad51
into nucleoﬁlaments (Fig. 5a, b). Indeed, we observe signiﬁcantly
elevated levels of RPA foci and pS4/8 RPA in parp1/2Δ cells,
despite their inability to form Rad51 foci in response to MMS
(Fig. 5a–c). We also observe a decrease in Rad51 foci in parp1/2Δ
cells exposed to HU that is accompanied by an increase in
replication fork degradation (Supplementary Fig. 12), indicating
the link between PARP1 and PARP2, Rad51 stabilisation in
chromatin and replication fork stability may be applicable more
generally. These observations are consistent with the reported role
of Rad51 in protecting stalled and damaged replication forks from
Mre11 and DNA2-dependent nucleolytic attack39,40,55,56 and can
be interpreted either as a defect in recruitment of Rad51 to
impaired replication forks and/or stabilisation of the Rad51
nucleoﬁlament. Importantly, depletion of Fbh1, an anti-
recombination helicase that destabilises Rad51 nucleoﬁla-
ments43,44,57, can restore MMS and HU-induced Rad51 foci in
parp1/2Δ cells or U2OS cells treated with olaparib (Fig. 5d, e).
Whereas this observation could reﬂect a shift in the equilibrium
between Rad51 loading and removal from nucleoﬁlaments,
depletion of Fbh1 cannot restore Rad51 foci in BRCA2 defective
cells, arguing against a role for PARP1/PARP2 in BRCA2-
dependent loading of Rad51 at damaged replication forks55.
Consistent with this hypothesis, enrichment of PALB2 into
chromatin following exposure of cells to MMS is not affected by
olaparib (Fig. 5f), a PARPi that targets both PARP1 and PARP2
and can suppress formation of Rad51 foci in response to MMS
(Fig. 4c). Instead, our data argue that PARPs act downstream of
BRCA2/PALB2 and function to stabilise Rad51 at the sites of
stalled/damaged replication forks.
In summary, our data point to the following model of how
PARP1 and PARP2 regulate repair of alkylated DNA damage by
two independent, but intrinsically linked mechanisms (Fig. 6):
PARP1 and PARP2 function redundantly in repair of alkylated
DNA base damage by promoting BER. However, removal of the
base and subsequent cleavage by APE1 results in a subset of SSBs
being converted to DSBs when they are encountered by active
replication forks. Under normal circumstances, limited nucleo-
lytic resection allows assembly of Rad51 at damaged replication
forks. PARP1 and PARP2 regulate this process by opposing the
role of Fbh1, either directly or indirectly, in destabilising Rad51 at
damaged replication forks. Therefore, under normal circum-
stances PARP1 and PARP2 function redundantly to stabilise
Rad51 nucleoﬁlaments, facilitating HR-dependent replication
fork repair. However, loss of PARP1 and PARP2 leads to defec-
tive BER, resulting in elevated levels of SSBs and consequently
replication-associated DNA damage. It also relieves the opposing
role of PARPs on Fbh1, resulting in disassembly of the Rad51
nucleoﬁlament, uncontrolled resection at stalled and/or damaged
replication forks, and an inability to repair DNA damage.
Methods
Cell culture and siRNA transfections. U2OS cells were a kind gift of L. Cox
(Department of Biochemistry, University of Oxford). U2OS cells were cultured in
DMEM supplemented with 10% FBS and 1% Pen/Strep. The identity of U2OS cells
and their derivatives were conﬁrmed by STR proﬁling. Flp-In T-Rex HT1080 cells
expressing FE-PALB2 were a kind gift of F. Esashi (Dunn School of Pathology,
University of Oxford), and were cultured in DMEM as above, supplemented with
100 μg/mL Hygromycin and 10 μg/mL Blasticidin. All cell lines were tested for the
absence of mycoplasma contamination.
Cells were transfected with 50 nM siRNA using Dharmafect-1 (Dharmacon),
transfected again after 24 h, then allowed to recover for 48 h before use. siRNA
SMARTpools were obtained from Dharmacon, either ON-Target Plus (PARP2,
XRCC1
SSBs
Repair
PARP2
S-phase
Base
alkylation
BER
HR
Rad51
filaments
Repair
Fbh1
Rad51
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PARP2
PARP1
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associated
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Fig. 6 PARP1 and PARP2 contribute to the resolution of DNA damage
caused by base alkylation through two mechanisms. Alkylated bases are
processed into DNA single-strand breaks during BER and their repair is
accelerated by XRCC1, PARP1 and PARP2. During S-phase, active
replication forks can collide with unrepaired SSBs, or SSB repair
intermediates, generating replication-associated DNA damage. This
damage can be resolved through homologous recombination, which
requires the formation of Rad51 ﬁlaments. PARP1 and PARP2 also
contribute to this mechanism by antagonising the anti-recombinogenic
activity of Fbh1, thus stabilising Rad51 nucleoﬁlaments
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PARP3 and Fbh1) or siGenome (XRCC1), and the appropriate non-targeting
control SMARTpool used for negative controls.
CRISPR cell line generation. Pairs of CRSIPR gRNAs were designed using the
MIT CRISPR design tool (http://crispr.mit.edu/), and cloned into pX462 or pX462
v2 (pSpCas9n(BB)-2A-Puro). gRNA sequences used were
TGGGTTCTCTGAGCTTCGGTGGG and CCACCTCAACGTCAGGGTGCCGG
for PARP1, CAAGGCCTTCACAGATTCTGAGG and GTTAAAGGGCAAA
GCTCCTGTGG for PARP2, and GCCTCAGCGGTGGAGCGGAAGGG and
AGAGAAGCGCATAATCCGCGTGG for PARP3.
U2OS cells were transfected with the appropriate gRNA constructs using
Turbofect according to manufacturer’s instructions, selected with 2–4 μg/mL
puromycin for 24 h, then plated at low density. Clonal colonies were isolated and
expanded, then screened for lack of the relevant protein by western blot. Gene
disruption was conﬁrmed using PCR and sequencing across the CRISPR target site
to characterise the mutations generated. Genomic DNA was prepared from
candidate cell lines by resuspending cells in DNA Extraction Buffer (10 mM Tris-
HCL pH 8.0, 1 mM EDTA, 25 mM NaCl and 200 μg/mL Proteinase K), heating to
65 °C for 30 min, then 95 °C for 2 min. After PCR ampliﬁcation, bands were cloned
into pJet1.2 (ThermoFisher) before analysis by Sanger sequencing. The parp1/2Δ
cells were generated by disrupting PARP1 in a parp2Δ cell line. Primer sequences
used were GCTTCCGCTGTCTTCTTGAC and TCGAGGTCAAGGTCAAGGTC
for PARP1, GTTTTTGATTCCCATAAAGTAGTACC and CATGGACTGAAG
ATCGGTTCC for PARP2, and AAGCCCTGGGTACAGACTGA and
GCTCCAAAACCAGAACAGAGTCC for PARP3.
Antibodies and chemicals. MMS (Sigma-Aldrich) or hydrogen peroxide (Sigma-
Aldrich) were freshly diluted into cell culture media directly before use. Cells were
treated with the indicated concentrations for 1 h, washed extensively with
phosphate-buffered saline (PBS), and allowed to recover in fresh media as neces-
sary. Olaparib (Cambridge Bioscience) was used at 10 μM, and cells were treated
with Olaparib 1 h prior to DNA damage. B02 (Sigma-Aldrich) was used at the
indicated concentrations. EdU was used at a ﬁnal concentration of 1 μM, and
added to cells simultaneously with DNA-damaging agents. Nu7441 (Tocris
Bioscience) was used at a ﬁnal concentration of 5 μM. CldU (Sigma-Aldrich) and
IdU (Sigma-Aldrich) were used at ﬁnal concentrations of 25 µM or 250 µM,
respectively, under conditions as described for the ﬁbre experiment. To induce
FE-PALB2 expression, Flp-In T-Rex HT1080 cells containing FE-PALB2 were
treated with 5 μg/mL Doxycyclin for 24 h.
Antibodies used in this study were anti-PARP1 (Bio-Rad, MCA1522G; dilution
1:1000), anti-PARP2 (Enzo, ALX-804-639L; dilution 1:50), anti-PARP3 (A kind
gift of F. Dantzer; Institut de Recherche de l’Ecole de Biotechnologie de Strasbourg,
France; dilution 1:2000), anti-Poly-ADP-Ribose binding reagent (Millipore,
MABE1031; dilution 1:1000), anti-XRCC1 (Abcam, ab1838; dilution 1:1000), anti-
Actin (Santa Cruz, SC-1615; dilution 1:1000), anti-γH2AX (Millipore, JBW301;
dilution 1:1000), anti-Rad51 (7946; a kind gift of F. Esashi; Dunn School of
Pathology, University of Oxford; dilution 1:1000), anti-RPA32 (Bethyl, A300-244A;
dilution 1:1000), anti-RPA32 S4/8 (Bethyl, A300-245A; dilution 1:1000), anti-GFP
(Roche, 11814460001; dilution 1:1000), anti-Fbh1 (Abcam, ab58881; dilution
1:100), mouse anti-BrdU (clone B44 recognising IdU, Becton Dickinson, 347580;
dilution 1:500) and rat anti-BrdU (clone BU1/75 recognising CldU, Bio-Rad,
OBT0030G; dilution 1:500).
Western blotting and cellular fractionation. Whole cell extracts were prepared
by boiling cells in 1 × SDS loading buffer for 5 min. Chromatin extracts were
prepared by washing cells in PBS before resuspending in extraction buffer 1 (10
mM Tris-HCl pH 7.5, 150 mM NaCl, 1.5 mM MgCl2, 340 mM sucrose, 10 %
glycerol, 1 mM DTT, 1 × Sigma protease inhibitors and 0.1% Triton X-100). The
samples were incubated on ice for 10 min, then centrifuged at 18,000 g for 5 min,
then the pellet resuspended in extraction buffer 2 (3 mM EDTA, 0.2 mM EGTA, 1
mM DTT, 1 × Sigma Protease Inhibitors) and incubated on ice for 30 min. Samples
were centrifuged again at 1800g for 5 min, and the pellet resuspended in 1 × SDS
loading buffer and boiled. Uncropped images of all blots are displayed in Sup-
plementary Fig. 13.
Clonogenic survival assays. U2OS cells were plated into 6-well plates and left
overnight. The following day, cells were exposed to DNA-damaging agents for 1 h,
washed extensively with PBS then allowed to recover in fresh media for 10–14 days.
For synthetic lethality experiments using Rad51 inhibition, cells were exposed to
B02 and/or Olaparib or Nu7441 for 48 h at the indicated doses, before washing
and recovery in fresh media. Cells were then ﬁxed in 100% methanol for 20 min at
−20 °C and stained with 0.5% Crystal Violet (Sigma-Aldrich) for 20 min. Colonies
of more than 50 cells were scored as viable.
Immunoﬂuorescence. Cells were plated onto glass coverslips and allowed to attach
overnight. Following DNA damage treatment, cells were ﬁxed with 4% paraf-
ormaldehyde for 20 min at 4 °C. Where necessary, prior to ﬁxation, soluble protein
was pre-extracted using 0.5% Triton X-100 in PBS for 5 min at 4 °C. Cells were
then permeabilised in 0.5% Triton X-100 in PBS for 5 min, and blocked in 3%
bovine serum albumin for 30 min. EdU was stained by incubation in reaction
buffer (100 mM Tris-Cl pH 8.0, 4 mM CuSO4, 50 mM sodium ascorbate, 20 μM
azide dye) for 30 min. Coverslips were stained with primary antibody (2 h, room
temperature), washed extensively in PBS-T, and stained with ﬂuorescently labelled
secondary antibody (1 h, room temperature). Following further PBS-T washing,
cells were mounted onto slides in Vectashield containing DAPI (Vector Labora-
tories). Samples were visualised using a Zeiss IX70 and × 100 oil immersion
objective lens. Each experiment was independently repeated at least three times,
with a total of at least 100 cells counted per condition. Images were processed in
ImageJ.
DNA ﬁbre analysis. Replication fork degradation assays following exposure of
cells to HU were performed as previously described55. In brief, to assess replication
fork stalling, cells were pulse-labelled with 25 µM CldU for 10 min prior to 40 min
co-incubation with 0.5 mM MMS. MMS-treated cells were washed trice with PBS
and released into fresh media containing 250 µM IdU for 0.5, 1 and 2 h before
harvesting. DNA ﬁbre spreads were prepared by spotting 2 µL of cell solution (5 ×
105 cells per mL PBS) onto microscope slides followed by lysis with 7 µL of lysis
buffer (0.5 % SDS, 200 mM Tris-HCl pH 7.4 and 50 mM EDTA). For spreading,
slides were tilted and subsequently ﬁxed in methanol/acetic acid (3:1). HCl-treated
ﬁbre spreads were treated with rat anti-BrdU (binding to CldU, clone BU1/75, Bio-
Rad, 1:500) and mouse anti-BrdU (binding to IdU, clone B44, Becton Dickinson,
1:500) for 1 h and subsequently ﬁxed with 4 % paraformaldehyde for 10 min to
increase staining intensity. Afterwards, slides were incubated with anti-rat IgG
AlexaFluor 555 and anti-mouse IgG AlexaFluor 488 (Molecular Probes) for 1.5 h.
Images were acquired on a Nikon E600 microscope using a Nikon Plan Apo ×60
(1.3 numerical aperture) oil lens, a Hamamatsu digital camera (C4742-95) and the
Volocity acquisition software (Perkin Elmer). Replication structures were analysed
using ImageJ (http://rsbweb.nih.gov/ij/) applying the cell counting plugin. At least
300 replication structures were assessed per condition.
Alkaline comet assays. The method was modiﬁed from a previously described
procedure to detect DNA strand breaks and alkali-labile sites58,59. Cells were
diluted to a concentration of 1 × 105/ml in PBS. The cell suspension was mixed
with an equal volume of warm 2% agarose solution (Type VII). A total of 500 μl of
the suspension was spread evenly onto poly-lysine coated slides that are pre-coated
with 0.3% agarose (Type 1). For cell lysis, the slides were soaked in 0.3 M NaOH/1
M NaCl/0.1% N-lauroylsarcosine, pH 11.5 in the dark for 1 h followed by two 30
min washes in 0.3 M NaOH, 2 mM EDTA. Slides were electrophoresed at 75 mA
for 30 min in the same buffer at pH 11.5. Following electrophoresis slides were
ﬂooded with neutralisation buffer (Tris-Cl pH 7.5) for 30 min. Slides were dried
overnight in the dark, and subsequently rehydrated in distilled water for 30 min in
the dark. Slides were stained with SYBR gold (1:10,000 in water) for 20 min and
then rinsed in water before leaving to dry overnight. The percentage DNA in the
tail and Olive moment were determined using OpenComet. The area and mean
pixel intensity of the head and the tail of the comets were measured to determine
the percentage DNA in the tail for the individual cell. For each experimental
sample 300 cells per time point (from duplicate slides) were analysed and the mean
Olive Moment was determined.
Quantiﬁcation and statistical analysis. In all cases, statistical signiﬁcance was
determined on at least three biological replicates. Within clonogenic survival assays
this was done by two-way analysis of variance. Within the fork resection assay this
was done using a Mann–Whitney rank sum test. In all other cases, this was done
using a two-tailed Student’s t-test. In each case, signiﬁcance is indicated as: NS, not
signiﬁcant; * p < 0.05; ** p < 0.01; *** p < 0.001.
Data availability. All data generated or analysed during this study are included in
this published article (and its supplementary information ﬁles) and available from
the authors upon reasonable request.
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